Skip to content

Clinical trials

Essential Hypertension trials in South Korea with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Status: Unknown status Country / region: South Korea Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20131
20142
20151
20201
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical3
Ahn-Gook Pharmaceuticals Co.,Ltd2
Addpharma Inc.1
HK inno.N Corporation1
Hanlim Pharm. Co., Ltd.1
Pacific Pharmaceuticals1
Seoul National University Bundang Hospital1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension11
Hypertension4
Angina, Stable1
Edema1
Heart Failure1
Isolated Systolic Hypertension1
Prehypertension1
Sleep Apnea, Obstructive1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.